Groundbreaking skull-fitted device can reduce epileptic seizure by 80%

A new UK clinical trial has shown that an innovative implantable device cam reduce the frequency and intensity of seizures in children with severe epilepsy by 80%.

This rechargeable device is attached to the skull and provides continuous electrical stimulation to the brain, resulting in significant improvements in patients’ quality of life.

Known as the CADET pilot (Children’s Adaptive Deep brain stimulation for Epilepsy Trial), this is the first trial to evaluate this treatment for pediatric epilepsy, indicating potential for wider use.

Unlike other Deep Brain Stimulation (DBS) devices, which are placed on the chest with wires running up to the brain, this device is mounted on the skull, making the leads less prone to damage or erosion as the child grows.